You are subscribed to the FormularyWatch.

Formulary

eNewsletter Subscribe

June 12, 2014

Web Version  | Share with a colleague

Facebook Like Twitter Tweet

Today's Headlines

FDA approves first hemophilia A drug to extend interval between prophylactic infusions in adults and children

FDA has approved Antihemophilic Factor (Recombinant), Fc Fusion Protein (Eloctate, Biogen Idec) for the control and prevention of bleeding episodes, perioperative (surgical) management and routine prophylaxis in adults and children with hemophilia A. » Full article

Merck to boost hep C drug portfolio with Idenix purchase

The acquisition of biopharmaceutical company Idenix Pharmaceuticals by Merck exemplifies the strong market opportunity in the hepatitis C market, according to industry watchers. » Full article

Continuing Education

MTM essentials for heart failure management

This month's article is the fifth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities form the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the stages and pharmacologic strategies relevant to medication therapy management of heart failure.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.


Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

 

Related Articles

FDA approves antihemophilic factor VIII for hemophilia A

Hepatitis C screening recommended by CMS for some beneficiaries

RESOURCES

Latest Clinical News

EDITOR'S PICK

Drugs in Context: Zohydro ER (hydrocodone bitartrate extended release)

Pain management is gradually becoming a topic of conversation and gaining considerable attention as it relates to providing quality services for those with acute or chronic pain ailments. Pain can affect millions of Americans and it contributes significantly to national rates of morbidity, mortality, and disability.» Full article

Powered by Modern Medicine Advanstar Medical Communications Group